Doctor in Medicine and Cardiovascular Surgery (MD, PhD) by the Autónoma University of Madrid, Spain. He received a Fellowship in Cardiothoracic Surgery and Investigation at the Harvard University (Boston, MA, USA); Fellowship in Cardiothoracic Surgery and Investigation at the Washington University (USA), Fellowship in Cardiothoracic Surgery at the Loma Linda University (California, USA), and Fellowship in Cardiothoracic Surgery at the University of Pennsylvania (Philadelphia, USA). He is also Doctor Honoris Causa in Medicine and Research by the Central East University (UCE) and the Nordestana Catholic University (UCNE) in the Dominican Republic.
On the Academic Front, Dr. Javier Cabo is the director of the Department of Health Sciences of the University of Madrid (UDIMA), and director and Chair of the Health Management and Health Studies of said University. He is also the Director and Chair of the Telemedicine Department (mHealth and uHealth) of the International University of Andalucia (UNIA); He is the Director and Chair of Biomedical Investigation and Hospital Management of the Nordestana Catholic University (UCNE) in the Dominican Republic; Director of the Department of Artificial Intelligence, Nanotechnology and Robotics of the Technology Research Center (CITEC) of the University of Cordoba (UCO), and Founder Member and Patron of the Foundation and Centre for Biomedical Engineering and Technologies of Spain.
Dr. Javier Cabo pioneered the first Centre for Cryopreservation of Cardiac Homografts based on the Cryolife method in the year 1992 in Spain, and also he performed the first infant heart transplant in Spain in the year 1994, and also the first External Artificial Heart Implant in a child in Spain in the year 2006, the world’s first Artificial Heart Implant with an Artificial Lung incorporated. He was former President of the Association of Cardiac Surgeons and is member of BIONECA (biomaterials and advanced physical techniques for regenerative cardiology and neurology). His current research focuses on artificial heart and mechanical circulatory support, stem cells, genomics, tissue preservation procedures and cryopreservation of large human organs.